ORLANDO, Fla.—The Association of Accessible Medicines’ annual meeting is back in person, and among the reminisces at the event was a 15 February panel that featured a fair bit of self-congratulation, albeit well deserved, about how the industry avoided a supply chain disaster at the beginning of the pandemic.
For Generics, A Victory Lap – And A Warning – On Drug Shortages
Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.
